Pen technology aids trial adaptations

Health Decisions has added digital pens to its adaptive clinical trial arsenal. The contract researcher is equipping investigators with pen/paper technology from Anoto, based in Sweden.

Investigators use the pens to log trial data; the pens record the data and convert it to digital format, says a trade publication. CRO and sponsor can then share the data once it's been downloaded and collated.

Health Decisions sees the technology as an aid to trial adaptation: It can keep both parties current with trial progress in a more timely fashion than that of more commonly used data-capture technologies. So trial managers will receive cues that drive trial adaptations earlier in the process.

- see the article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.